Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
9%
OVERLAP
BY WEIGHT
4
# OF OVERLAPPING
HOLDINGS
HART
69
HOLDINGS
7%
ALSO IN XPH
XPH
54
HOLDINGS
8%
ALSO IN HART
SECTOR DRIFT (HART minus XPH)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in HART |
Weight in XPH |
Overlap | |
|---|---|---|---|---|
 |
JOHNSON & JOHNSON | 6.6% | 2.4% | 2.4% |
|
BRISTOL-MYERS SQUIBB CO | 3.5% | 2.3% | 2.3% |
|
PFIZER INC | 5.2% | 2.1% | 2.1% |
|
ELI LILLY & CO | 7.2% | 2.0% | 2.0% |
HART Overweight Relative to XPH
|
ALPHABET INC. CLASS A | 9.0% |
|
APPLE INC | 6.7% |
 |
ASTRAZENECA PLC | 6.4% |
 |
NOVARTIS AG | 6.0% |
|
UNITEDHEALTH GROUP INC | 5.4% |
|
ELI LILLY & CO | 5.2% |
|
ABBOTT LABORATORIES | 4.6% |
|
BOSTON SCIENTIFIC CORP | 4.5% |
|
JOHNSON & JOHNSON | 4.2% |
 |
MEDTRONIC PLC | 4.0% |
HART Underweight Relative to XPH
|
DEFINIUM THERAPEUTICS INC | -3.0% |
|
EDGEWISE THERAPEUTICS, INC. | -2.5% |
|
ROYALTY PHARMA PLC CLASS A | -2.4% |
|
MERCK & CO. INC. | -2.4% |
|
VIATRIS, INC. | -2.4% |
|
PHIBRO ANIMAL HEALTH CORP-A | -2.3% |
|
LIQUIDIA TECHNOLOGIES, INC. | -2.3% |
|
LIGAND PHARMACEUTICALS-CL B | -2.2% |
|
JAZZ PHARMACEUTICALS PLC | -2.2% |
|
SUPERNUS PHARMACEUTICALS INC | -2.2% |